LOTTE Chemical’s Anti-virus Material ‘everban’ Applied to Credit Cards
■ Application of ‘everban,’ a material the suppresses harmful microorganisms such as germs, molds, viruses, etc. on LOTTE credit cards such as 『LOTTE Department Store Living by Lola LOTTE Card』
■ Satisfy the required features for manufacturing credit cards such as extrusion, adhesiveness, and visibility... Can be applied in a wide range of areas throughout everyday life such as interior materials and medical equipment
■ Even prior to the COVID-19 pandemic, identified the wellbeing trends and consumer interests on hygienic products, and then focusing on developing antibacterial and anti-virus materials
The ‘LOTTE Department Store Living by Lola LOTTE Card’ credit card that applied the harmful microorganism suppression material ‘everban’ of LOTTE Chemical (Advanced Materials Division CEO Lee Young-jun) was issued by LOTTE Card starting on December 29.
everban, which is an anti-virus plastic material jointly research, developed, and evaluated with Korea University Medical Center, is a plastic material that includes technologies that can suppress germs, molds and viruses, and it applies general platform technologies to suppress harmful microorganisms in accordance to consumer interests on life and safety as it can protect people from various infections in everyday life.
LOTTE Chemical collaborated with a card manufacturer to satisfy the basic attributes required of credit cards such as extrusion, adhesiveness, and visibility. It was explained that with this application on credit cards it can also be used in a variety of other areas such as interior materials, medical equipment that are sensitive to hygiene and safety, handles that have high contact frequency, elevator films, decorative sheets, etc.
Even before the breakout of COVID-19, LOTTE Chemical identified the wellbeing trends consumer interest in hygienic materials, and recognized the need for antibacterial materials, thus focusing on developing antibacterial and anti-virus materials. It developed the first-generation antibacterial technology evermoin in 2017 and then everban that added anti-virus functions to antibacterial technologies in 2021.